EPA-Enriched Phospholipids Alleviate Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating TGF-β Signaling Pathways

Hypertensive nephropathy is a chronic kidney disease caused by hypertension. Eicosapentaenoic acid (EPA) has been reported to possess an antihypertensive effect, and our previous study suggested that EPA-enriched phospholipid (EPA-PL) had more significant bioactivities compared with traditional EPA....

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hao-Hao, Zhang, Ling-Yu, Chen, Li-Pin, Yang, Jin-Yue, Wang, Cheng-Cheng, Xue, Chang-Hu, Wang, Yu-Ming, Zhang, Tian-Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879699/
https://www.ncbi.nlm.nih.gov/pubmed/35200681
http://dx.doi.org/10.3390/md20020152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879699/
https://www.ncbi.nlm.nih.gov/pubmed/35200681
http://dx.doi.org/10.3390/md20020152

Ejemplares similares